George Flores

As Cipla rolls out its affordable Liraglutide injection, the battle for the multi-billion dollar GLP-1 market intensifies, promising greater access for patients.

Electric outboard maker Flux Marine hires Mercury Marine's former strategy head, signaling a push from niche tech to mainstream market dominance.

As UFP Technologies preps for a key investor conference, its stellar growth, strategic acquisitions, and vital role in the MedTech supply chain are in focus.

Startup World Cup's 'East Meets West' event positions Hawaii as a crucial hub for cross-Pacific innovation, with a $1M prize and Tim Draper in attendance.

Awarded India's fastest growing payments app, super.money is using a unique micro-credit model to bring millions of young Indians into the formal economy.

A new plan offers to wipe out electricity usage bills for Aussie solar homes, but does the 'zero bill' dream come with a catch? We investigate.

Japan's Ministry of Defense partners with TIER IV to deploy autonomous ground vehicles, aiming to solve manpower shortages and modernize national security.

The AI semiconductor firm posts 37% annual revenue growth and a return to non-GAAP profit, proving its strategic pivot to intelligent edge devices is a success.

Jacobi Strategies unveils a new AI-assisted coding platform, enabling investment firms to build bespoke applications in a secure, private environment.

As wildfire losses soar, new actuarial guidelines aim to reshape Canada's insurance landscape. What does this mean for your policy and premiums?

Verifiable's new CredAgent™ promises to slash credentialing times and costs, challenging the industry's reliance on manual labor and offshore outsourcing.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

Following major growth, fraud prevention leader Entersekt bolsters its leadership with top talent to scale its Context Aware™ Authentication platform globally.

A new exclusive deal pairs NeutronX's AI and federal access with NextNRG's energy tech, aiming to overhaul critical U.S. infrastructure and national security.

Investors sue Corcept Therapeutics, claiming the company hid FDA warnings about its key drug, relacorilant, before a 50% stock price collapse.

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.

Groundbreaking research shows AI's information diet is dangerously imbalanced, creating an unseen force that could manipulate public opinion and erode democracy.

A new partnership aims to end the fragmented and costly process of healthcare compliance by merging a GRC platform with expert assessment services.

As Fred Strong and Jewel Edson take the helm of the LOSSAN rail agency, they face urgent threats of coastal erosion, funding battles, and infrastructure needs.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?